In which of the following condition oral contraceptive pills (OCPs) should not be used?

RML Lucknow - 2021

Pharmacology

Easy

Appeared in: RML Lucknow - 2021

Explanation

Combined oral contraceptives (COCs) contain estrogen, which increases the liver's synthesis of angiotensinogen. This can lead to a rise in blood pressure.
For women with pre-existing hypertension, this effect significantly elevates their risk of serious cardiovascular events like stroke and myocardial infarction.
The estrogen component also increases the production of clotting factors, raising the risk of venous thromboembolism (VTE), a danger that is compounded by hypertension.
Due to these unacceptable health risks, the World Health Organization (WHO) classifies COC use in women with severe hypertension (BP greater than or equal to 160/100 mmHg) as a Category 4 contraindication (do not use).

Option A: Anaemia is not a contraindication. In fact, OCPs are often prescribed as a non-contraceptive benefit for women with heavy menstrual bleeding, a common cause of iron-deficiency anaemia.
Option C: A history of caesarean section is not a contraindication for OCP use. Hormonal contraceptives are typically initiated after the immediate postpartum period (3-6 weeks) when the risk of thrombosis from surgery and delivery has subsided.
Option D: Obesity is a relative contraindication (WHO Category 2), not an absolute one. While obesity increases the baseline risk for VTE, the benefits of OCPs often outweigh the risks, provided other cardiovascular risk factors are absent.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Contraindications for Oral Contraceptive Pills (OCPs) as background academic context rather than a clinical decision trigger.
Nurses must perform a thorough screening before OCP initiation, including an accurate blood pressure measurement and a detailed medical history to identify contraindications like hypertension.
Patient education is critical. Nurses should teach the 'ACHES' acronym for VTE warning signs: Abdominal pain, Chest pain, Headaches (severe), Eye problems (vision changes), and Severe leg pain.
What if the patient has well-controlled hypertension? This is a WHO Category 3 condition, meaning the risks usually outweigh the benefits. Safer alternatives, such as progestin-only methods (mini-pill, implant) or non-hormonal methods (copper IUD), should be strongly recommended.

How to Approach the Question

First, identify that the question is asking for a contraindication to OCP use, meaning a condition that makes them unsafe.
Recall the main components of combined OCPs (estrogen and progestin) and their significant side effects.
Focus on the cardiovascular and thromboembolic risks associated with the estrogen component, which include increased blood pressure and blood clot formation.
Evaluate each option in light of these risks: Anaemia is often improved by OCPs. A history of C-section is not a long-term contraindication. Obesity is a relative risk factor. Hypertension is a direct cardiovascular condition that is worsened by OCPs.
Conclude that hypertension presents an unacceptable risk when combined with the physiological effects of OCPs, making it the correct answer.

Concept Tested & Keywords

Concept Tested: Contraindications for Oral Contraceptive Pills (OCPs)
Stem keywords: oral contraceptive pills, OCPs, should not be used, condition
Lead-in keywords: not
Negative lead-in flag: The question asks for a condition where OCPs should NOT be used, which means you need to identify the contraindication among the given options.

QS0I_DVBSniMoNTPc5FNZA

E6 Obstetrics Williams p. 82-94

E6 Pharmacology KD Tripathi Essentials 9e Part 1 p. 379-380